171 related articles for article (PubMed ID: 8631805)
1. Activated neu induces rapid tumor progression.
Guy CT; Cardiff RD; Muller WJ
J Biol Chem; 1996 Mar; 271(13):7673-8. PubMed ID: 8631805
[TBL] [Abstract][Full Text] [Related]
2. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P
Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.
Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ
Mol Cell Biol; 1996 Oct; 16(10):5726-36. PubMed ID: 8816486
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
[TBL] [Abstract][Full Text] [Related]
5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
6. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.
Bouchard L; Lamarre L; Tremblay PJ; Jolicoeur P
Cell; 1989 Jun; 57(6):931-6. PubMed ID: 2567634
[TBL] [Abstract][Full Text] [Related]
7. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
[TBL] [Abstract][Full Text] [Related]
9. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
10. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
12. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.
Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA
Cancer Cell; 2002 Dec; 2(6):451-61. PubMed ID: 12498714
[TBL] [Abstract][Full Text] [Related]
13. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
Bradbury JM; Arno J; Edwards PA
Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
[TBL] [Abstract][Full Text] [Related]
14. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Siegel PM; Dankort DL; Hardy WR; Muller WJ
Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422
[TBL] [Abstract][Full Text] [Related]
15. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice.
Masuelli L; Marzocchella L; Focaccetti C; Lista F; Nardi A; Scardino A; Mattei M; Turriziani M; Modesti M; Forni G; Schlom J; Modesti A; Bei R
Cancer Immunol Immunother; 2010 Aug; 59(8):1247-58. PubMed ID: 20364378
[TBL] [Abstract][Full Text] [Related]
18. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
19. A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene.
Weinstein EJ; Kitsberg DI; Leder P
Mol Med; 2000 Jan; 6(1):4-16. PubMed ID: 10803404
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
